The inhibition of decreased PGC‐1α expression caused an improvement in decreased mitochondrial oxidative capacity in the skeletal muscle via inhibition of increased blood glucose levels in diabetes conditions (Nakamoto & Ishihara, 2020). Here, PPARGC1A is linked to diabetes mellitus.